StockWatch
·
Pharmaceuticals
Quarterly Result29 May 2026, 07:01 pm

Mercury Labs: Corrigendum to FY26 Audited Results

AI Summary

Mercury Laboratories Ltd has issued a corrigendum to its audited financial results for the quarter and year ended March 31, 2026, due to a typographical error in the balance sheet under current liabilities and an omission in cash flow from financing activities. The corrected financial results, along with the auditor's report, have been resubmitted. The board had earlier recommended a final dividend of 35% i.e ₹3.50 per share for FY26, subject to shareholder approval.

Key Highlights

  • Mercury Labs corrects typographical error in FY26 balance sheet under current liabilities.
  • Cash flow statement revised due to omission in financing activities section.
  • Audited financial results and auditor's report resubmitted after corrections.
  • Final dividend of ₹3.50 per share recommended for FY26, pending shareholder approval.
  • Statutory Auditors expressed an unmodified opinion on the FY26 results.